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Received 24 September 2014; accepted 17 November 2014AbstractECAPs are the summary of multiple neurons’ spikes which could be recorded by a bidirectional stimulation-recording system via the
cochlear implant, with the artifact elimination paradigms of forward-masking subtraction paradigm or alternating polarity paradigm. Three kinds
of FDA approved cochlear implants support ECAP testing. This article is to summarize the clinical application of ECAP test. ECAP test after
insertion of electrode during implant operation has been widely used during cochlear implant surgery. In recent years, ECAP thresholds are also
used to estimate the T levels and C levels helping programming. However, correlation between ECAP thresholds and psychophysical thresholds
is affected by many factors. So far, ECAPs cannot yet be a good indicator of post-operative hearing and speech performance.
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were originally applied to research the neural response of
animals to electrical stimulation. With the development of
cochlear implant, it is possible to record human neural ECAPs
in vivo through implanted electrodes (Abbas et al., 1999). So
far, there are three kinds of FDA approved cochlear implants
that support ECAP testing, which widen the clinical applica-
tion of ECAPs, including: 1) evaluation of response of the
VIIIth nerve to electrical stimulation, helping to validate the
working status of implant; 2) assisting speech processor pro-
gramming; and 3) evaluation of spatial excitation patterns and* Funding: This work was supported by grants from the National Basic
Research Program of China (973 Program) (#2012CB967900), Science and
Technology Innovation Nursery Foundation of PLA General Hospital
(13KMM14) and Clinical Research Supporting Foundation of PLA General
Hospital (2012FC-TSYS-3056).
* Corresponding author.
E-mail addresses: argfei301@163.com (J. Fei), yangsm301@263.net
(S. Yang).
Peer review under responsibility of PLA General Hospital Department of
Otolaryngology Head and Neck Surgery.
http://dx.doi.org/10.1016/j.joto.2014.11.002
1672-2930/Copyright © 2014, PLA General Hospital Department of Otolaryngolog
Ltd. All rights reservedinter-electrodes interference which may be related to post-
operative speech performance. The aim of this paper is to
summarize the clinical application of ECAP test.1. ECAP test methods
Similar to the compound action potentials (CAPs) in
EcochG, ECAPs are the summary of multiple neurons' spikes,
reflecting the neural synchronization under electrical stimu-
lation, and can be recorded by a bidirectional stimulation-
recording system via the implanted multichannel electrodes.
As an objective test, ECAP does not require active participa-
tion by the patient, and the recordings are not adversely
affected by attention or sleep, making this response an ideal
tool for monitoring long-term changes. Being near-field
recording response, both the stimulating electrode and
recording electrode of ECAPs are around the spiral ganglion,
which leads to relative large and robust amplitudes than those
of far-field electrically evoked auditory brainstem responses
(EABRs). Furthermore, in ECAPs test, relative few sweeps
and thus shorter recording time, no skin preparation or anyy Head and Neck Surgery. Production and hosting by Elsevier (Singapore) Pte
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needed, which makes ECAPs more suitable to be widely used
in clinical practice than EABRs.
A typical ECAP pattern comprises two main waveforms,
including a negative wave with a latency of 0.2e0.4 ms (N1),
and a positive peak or platform with a latency of 0.6e0.8 ms
(P1) (Abbas et al., 1999). Because of the short latency and
relatively small amplitude than stimulus, it is necessary to
eliminate the stimulating artifact to avoid ECAP waveforms
being swamped by them. There are two kinds of artifact
elimination paradigms applied in mainstream implant systems,
as following.
1) Forward-Masking Subtraction Paradigm
Charlet de Sauvage et al. (1983) and Brown et al. (1990)
have suggested this paradigm which subtracts the artifact
from the recording to extract the relatively miniscule neural
response from the accompanying stimulus artifact. This
forward-masking paradigm involves three stimulation in-
tervals. With sufficient forward-masking, the neural response
can be acquired by subtraction among data obtained from
different intervals (Abbas et al., 1999; Xi et al., 2009). Be-
sides, Klop et al. have introduced a dual-masker forward
masking technique based on this paradigm, to measure elec-
trode independency in a cochlear implant and evaluate the
possibility of determining the optimal locations and number of
active electrodes (Klop et al., 2009).
2) Alternating Polarity Paradigm
This method is similar to that used in acoustic ABR test.
Electrical pulses with alternating polarities are used to stim-
ulate the spiral ganglion. Artifacts are to be canceled out from
stimuli polarity reversion, while the neural response, whose
polarity does not reverse with the stimuli, is not affected by
stimulus polarity reversion. After repeated sweeps, most of the
artifacts are eliminated and ECAP components are enhanced.
ECAP thresholds obtained by this paradigm is somewhat
higher than those from forward-masking paradigm (Xi et al.,
2009).
In three models of FDA approved cochlear implants,
ECAPs can be recorded by a percutaneous technique named
telemetry, via bidirectional stimulation-recording systems.
ECAPs tests were first clinically introduced in Nucleus
CI24M which is equipped with Neural Response Telemetry
(NRT) that allows the intra-cochlear electrodes to be used
both for stimulation and recording purposes (Abbas et al.,
1999). The forward-masking subtraction paradigm is used in
the NRT test, making it possible to measure the response of
the auditory nerve to electrical stimulation without adverse
effects by artifacts. NRT test was approved by FDA in 1998.
The Neural Response Imaging (NRI) software was introduced
by Advanced Bionics Corporation in 2002 (Frijns et al.,
2002), and was approved by FDA in 2003. The ECAP test
software from Med-EL was introduced as Auditory Nerve
Response Telemetry (ART), with the alternating polarityparadigm to eliminate artifacts, which obtained approval by
FDA in 2007. In each product, a built-in recognition algorithm
is applied to analyze the amplitude of N1eP1, and an
amplitude growth function can be obtained using stimulation
of different levels to demonstrate the correlation between
stimuli intensity and ECAP amplitude, and the ECAP
thresholds can be calculated.
2. ECAPs in intra-operative monitoring
ECAP test after insertion of electrode has been widely used
during cochlear implant surgery. In China, an intra-operative
ECAP incidence of more than 85% has been reported (Su-
ying et al., 2006; Hua et al., 2001). Even in patients with
Mondini syndrome, the intra-operative ECAP incidence may
reach 60% (Hua et al., 2001). Generally, clear differentiation
of intra-operative ECAP waveforms reflects appropriate
insertion position and normal activation of intra-cochlear
electrodes. However, the absence of intra-operative ECAP
does not necessarily imply deactivation or absent neural
response. In 20% of such cases, electrodes provide a useful
auditory sensation and patients show good postoperative out-
comes in spite of deterioration or absence intra-operative
ECAPs (Alvarez et al., 2010).
3. ECAPs in cochlear implant programming
In recent years, importance has been attached to the role
ECAPs play in speech processor programming. The relation-
ship between ECAP thresholds and MAP levels has been
studied to help programming in some patients who cannot
cooperate in a psychophysical process to identify the audible
threshold and comfort level boundaries (the T- and C-levels,
respectively). ECAP thresholds are then used to estimate the T
levels and C levels.
Restricted to the state of arts, early studies were based on
Nucleus 24M with relatively low stimulate rate in SPEAK
coding strategy and straight electrode arrays. In young chil-
dren, ECAP thresholds tend to be at the middle of stimulation
dynamic range confined by T level and C level. In adults,
ECAP thresholds are more likely at 90% of the dynamic range,
close to C levels. Moreover, 1/3 of adults have ECAP
thresholds higher than C levels. T levels are always lower than
ECAP thresholds. In some studies, the correlation between T
levels and ECAP thresholds is modest, with correlation co-
efficients of 0.5e0.9. The correlation between C levels and
ECAP thresholds are drastically variable from 0.1 to 0.9
(Hughes et al., 2000; Polak et al., 2005), which indicates that
ECAP thresholds are not a reliable predictor of psychophysical
results. However, ECAP thresholds have similar profile along
electrodes as indicated by MAP profile obtained from psy-
chophysical test, which suggests it is possible to induce MAP
profile from ECAPs to help programming. In the case that
profiles of T levels or C levels have large differences from
ECAP profiles at some electrodes, psychophysical thresholds
can be adjusted according to ECAP profiles, especially for T
levels (Hughes et al., 2001).
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stimulate rate has been increased greatly. These two factors
will influence the psychophysical thresholds, and consequently
the correlation between ECAPs and psychophysical thresh-
olds. Besides, the introduction of NRI and ART has provided
additional approaches to research the new trends in correlation
between ECAPs and psychophysical thresholds (Alvarez et al.,
2010; Polak et al., 2005; Botros and Psarros, 2010; Eisen and
Franck, 2004; Han et al., 2005; Holstad et al., 2009; Jeon
et al., 2010; Potts et al., 2007). According to the results
from studies with both Nucleus Freedom 24RE (Gordin et al.,
2009) and Advanced Bionics CII implant (Eisen and Franck,
2004), ECAPs and behavioral thresholds (T levels, C levels/
M levels) can be significantly lowered by pre-curved arrays
compared with straight arrays. The largest reductions of ECAP
thresholds are observed upon apical and basal electrode
stimulation. Meanwhile, in pre-curved electrode arrays, ECAP
thresholds have moderate correlation with T levels and C
levels (Polak et al., 2005). The standard electrode array for the
MED-EL MAESTRO cochlear implant system allows a deeper
insertion. This long electrode array is capable of stimulating
the most apical region of the cochlea, and significant higher
ECAP amplitude, lower thresholds and steeper amplitude
growth function slopes can be observed in the apical region
(Brill et al., 2009).
Increasingly higher stimulation rates have been used in
cochlear implant speech coding strategies, in order to improve
temporal resolution. The initial stimulation rate in SPEAK
coding strategy of Nucleus was 250 PPS, while in ACE
strategy it has been improved up to 900e1800 PPS. In the
HiRes strategy of Advance Bionics about 3000 PPS stimula-
tion rate per channel is used. Patient temporal resolution can
be improved with the improvement of stimulation rate, while
T levels and C levels drop accordingly. However, considering
the refractory period and adaptation of nerve fibers to the
stimulation rate, ECAP test cannot use extremely stimulation
rates (Lai and Dillier, 2009). In the case of fast stimulation,
ECAP thresholds may be close to or over the C levels or M
levels, sometimes even twofold of the M level, which may
affect correlation between ECAP threshold and behavioral
thresholds (Eisen and Franck, 2004; Han et al., 2005; Holstad
et al., 2009; Jeon et al., 2010; Potts et al., 2007). Thresholds
for all electrodes decrease between surgery and initial stimu-
lation and remain relatively stable at 3 months poststimulation.
ECAP thresholds are consistently lower for children compared
with adults. ECAP thresholds and amplitude growth functions
will change very little over a 5e6 year observation interval
(Brown et al., 2010; Wesarg et al., 2010). Significant differ-
ences have been found in ECAP thresholds of different elec-
trode positions. Basal electrodes had higher ECAP thresholds
than apical electrodes and that relationship was consistent for
each time period (Su-ying et al., 2006; Hua et al., 2001; Brill
et al., 2009; Spivak et al., 2010). Mid-array ECAP thresholds
showed the least amount of change over time, suggesting
ECAP thresholds obtained intraoperatively at these electrodes
may be helpful in creating a first MAP when no otherbehavioral or electrophysiological data are available (Spivak
et al., 2010).
Statistically, the correlation between ECAP threshold and
behavior threshold (T level) would not increase with the
stimulation rate, and even goes to opposite direction (Botros
and Psarros, 2010; Wesarg et al., 2010). Further research
revealed stronger correlation between ECAP threshold and C
level than that between ECAP threshold and T level (Botros
and Psarros, 2010; Holstad et al., 2009; Potts et al., 2007).
ECAP thresholds recorded from Advanced Bionics cochlear
implant users always indicated T levels. However, the corre-
lation between ECAP thresholds and M-levels (the primary
metric used to program the speech processor of the Advanced
Bionics CI) was modest (correlation coefficient ¼ 0.56e0.74).
If programming levels are to be determined on the basis of
ECAP thresholds, the stimulation may be uncomfortably loud,
particularly on the basal electrodes (Eisen and Franck, 2004;
Han et al., 2005; Jeon et al., 2010). In Med-El Tempoþ
Cochlear Implant Speech Processor, estimation of T levels has
less effect on hearing quality than that of C levels, and the
correlation between ECAP thresholds and C levels is also mild
(correlation coefficient ¼ 0.53) (Alvarez et al., 2010).
The correlation between ECAP thresholds and psycho-
physical thresholds is affected by many factors. 1) Electrode
locations. ECAP thresholds are significantly higher for re-
cordings from the basal side of the probe versus apical
(Hughes and Stille, 2009). 2) Psychophysical test signals. It
has been reported that correlation between ECAP thresholds
and M levels obtained by tone burst is higher than that ob-
tained by speech burst in AB cochlear implant (Jeon et al.,
2010). 3) ECAP thresholds calculation. It has been reported
that thresholds manually calculated from ECAP amplitude
growth function are higher than those from an automatic linear
regression in NRI test (Han et al., 2005; Potts et al., 2007).
Similarly, because stimulation rates cast different influences
on the forward-masking subtraction paradigm and the alter-
nating polarity paradigm in artifact elimination, ECAPs from
these two paradigms may demonstrate different thresholds,
which consequently result in different correlations (Eisen and
Franck, 2004). To sum up, in devices applying coding a
strategy with high stimulation rate, the correlation between
ECAP thresholds and T/C levels varies depending on electrode
positions and individual patients. Reasonable methods should
be used in predicting T/C levels from ECAPs. Botros and
Psarros (2010) has suggested a profile scaling model con-
structed from the data prescribing a flattening of the ECAP
threshold profile by a simple linear regression. The scaled
ECAP threshold profile method provides a clinically signifi-
cant enhancement to ECAP-based fitting methods, confirming
the value of the ECAP threshold profile to cochlear implant
fitting. Alvarez et al. (2010) provided a normalization proce-
dure, by which ECAP measurements allow the C-level profile
to be predicted with a mean relative error of 6%. On the other
hand, even limited behavioral responses (e.g. T/C levels ob-
tained in a few separate electrodes) can help improve the
correlation greatly when they are combined with ECAP
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Eisen and Franck, 2004).
4. ECAPs and post-operative speech recognition
Another research focus is the relationship between ECAP
characteristics and patient speech recognition. In multi-
channel cochlear implants (CIs), spectral representation of
the signal is achieved by stimulation of various electrodes
located along the longitudinal axis of the cochlea. Current
from each electrode creates an electric field that stimulates
surrounding neural tissue. Current fields tend to overlap with
one another to some extent, which may affect speech
perception with the implant. For CI users, the ability to
discriminate electrodes on the basis of pitch is likely influ-
enced by the spatial overlap of stimulated neural populations.
Spread of excitation patterns (SOE function) for CI electrodes
can be measured with the ECAPs, SOE function may help
predict patient speech recognition outcomes objectively (Xi
et al., 2009; Hughes and Stille, 2008). Two different
methods can be used to measure SOE. One test method is to
fix stimulation electrode and shift recording electrode along
the electrode array while recording the ECAP amplitude as a
function of the recording electrode position, known as exciting
spatial spread function. Another method is used in the
forward-masking subtraction paradigm in which the probe
pulse is presented on one electrode and the masker is shifted
along electrode array. The response to the masked probe is
dependent on the extent of SOE. The waveform as a function
of masker electrode then reflects the degree of overlap be-
tween the population of neurons responding to the masker and
those stimulated by the probe, which is known as spatial
masking function (Hughes and Stille, 2010). However, the
correlation between ECAP test and psychophysical test is still
not definite. Some studies have found that the more excited
space overlapping, the worse the pitch recognition in patients.
While some other studies found no significant relationships
between pitch recognition and the SOE functions (Busby
et al., 2008). In view of this situation, ECPAs cannot be
used to predict speech recognition separately until they are
combined with psychophysical tests (Hughes and Stille, 2008).
In addition to SOE, other characteristics of ECAPs may also
help predict speech performance. Kim et al. (2010) suggested
that slope of the ECAP growth can show significant correla-
tion to performance with a cochlear implant, especially in
patients using Hybrid RE CI. Cohen (2009) provided a model
which was fitted to ECAP recovery data in a case where the
masker current was highly correlated to that of the probe and
masking assumed to be almost complete. The model should
provide the means to improve speech processing algorithms
for cochlear implants, by allowing the systematic incorpora-
tion of additional information concerning the neural response
to electrical stimulation. Besides, JI Fei et al. studied ampli-
tudes of ECPAs in cochlear implantees with auditory neu-
ropathy, reporting low incidence, low differentiation and large
variation as the characteristics. However, ECAPs cannot yet bea good indicator of post-operative hearing and speech per-
formance in these patients (Fei et al., 2014).
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